venBio Partners LLC - PHARVARIS N V ownership

PHARVARIS N V's ticker is PHVS and the CUSIP is N69605108. A total of 21 filers reported holding PHARVARIS N V in Q2 2022. The put-call ratio across all filers is - and the average weighting 2.4%.

Quarter-by-quarter ownership
venBio Partners LLC ownership history of PHARVARIS N V
ValueSharesWeighting
Q2 2024$80,638,915
-18.6%
4,289,3040.0%34.83%
-0.9%
Q1 2024$99,125,815
-28.2%
4,289,304
-12.8%
35.16%
+70.0%
Q4 2023$137,992,087
+55.0%
4,919,504
+15.4%
20.68%
-18.1%
Q3 2023$89,003,705
+37.8%
4,264,6720.0%25.24%
+8.0%
Q2 2023$64,567,134
+251.8%
4,264,672
+87.2%
23.37%
+129.7%
Q1 2023$18,353,922
-29.0%
2,278,575
-0.8%
10.17%
+27.0%
Q4 2022$25,837,988
+46.7%
2,296,7100.0%8.01%
+96.5%
Q3 2022$17,616,000
-65.4%
2,296,710
-0.2%
4.08%
-71.9%
Q2 2022$50,862,000
+21.8%
2,301,451
-0.1%
14.48%
+56.4%
Q1 2022$41,771,000
+26.0%
2,303,3100.0%9.26%
+55.1%
Q4 2021$33,145,000
-18.8%
2,303,3100.0%5.97%
+46.8%
Q3 2021$40,838,000
-4.8%
2,303,3100.0%4.07%
-19.7%
Q2 2021$42,911,000
-33.4%
2,303,3100.0%5.06%
-17.3%
Q1 2021$64,447,0002,303,3106.12%
Other shareholders
PHARVARIS N V shareholders Q2 2022
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 3,246,926$71,757,00019.32%
venBio Partners LLC 2,301,451$50,862,00014.48%
Bain Capital Life Sciences Investors, LLC 3,180,601$70,291,0008.24%
5AM Venture Management, LLC 587,600$12,986,0003.21%
Cormorant Asset Management, LP 1,145,953$25,326,0001.92%
GENERAL ATLANTIC, L.P. 2,420,155$53,485,0000.70%
SUVRETTA CAPITAL MANAGEMENT, LLC 827,540$18,289,0000.70%
Novo Holdings A/S 519,339$11,477,0000.56%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,190,343$26,307,0000.54%
Foresite Capital Management V, LLC 34,142$755,0000.53%
View complete list of PHARVARIS N V shareholders